YS Biopharma Co., Ltd. (YS)
NASDAQ: YS · IEX Real-Time Price · USD
1.60
-0.44 (-21.57%)
At close:
Mar 31, 2023, 4:00 PM
1.61
+0.01 (0.63%)
After-hours:
Mar 31, 2023, 7:58 PM EDT
-21.57%
(1D)
| Market Cap | 147.48M |
| Revenue (ttm) | 131.39M |
| Net Income (ttm) | -46.04M |
| Shares Out | 92.18M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,694,992 |
| Open | 2.06 |
| Previous Close | 2.04 |
| Day's Range | 1.44 - 2.10 |
| 52-Week Range | 1.44 - 18.44 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 30, 2023 |
About YS
Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong. [Read more]
Industry
Shell Companies
Sector
Financials
Founded
2002
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
YS
News
YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION
Business Combination to deliver approximately $36 million of gross proceeds YS Biopharma expects to close the Business Combination on March 16, 2023 YS Biopharma Ordinary Shares and YS Biopharma Warra...
2 weeks ago - PRNewsWire
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION
Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held on March 1, 2023 at 9:00 a.m. Eastern Time YS Biopharma is a global biopharmaceutical company dedicated t...
1 month ago - PRNewsWire